Immunosuppressive treatment of Berger's disease

Clinical Pharmacology and Therapeutics

Volumn 60, Issue 5, 1996, Pages 561-567

  Faedda, Rossana ^b   Pirisi, Mario ^b   Satta, Andrea ^b   Bosincu, Luisanna ^b   Bartoli, Ettore ^a  

^a UNIVERSITY HOSPITAL OF UDINE   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; PREDNISONE;

ADOLESCENT; ADULT; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DRUG EFFICACY; FEMALE; HEMATURIA; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEINURIA; TREATMENT OUTCOME;

EID: 0029842615     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(96)90152-6     Document Type: Article

References (35)

1. Berger J, Hinglais N. Les dépots intercapillaire d'IgA-IgG. J Urol Nephrol (Paris) 1968;74:694-5.
2. Lee SMK, Rao VM, Franklin WA, Schiffer MS, Aronson AJ, Spargo BH, et al. IgA nephropathy: morphologic predictors of progressive renal disease. Hum Pathol 1982;13:314-22.
3. Hall RP, Stochura I, Cason J, Whiteside TL, Lawley TJ. Circulating IgA complexes in nephropathy. Am J Med 1983; 74:56-61.
4. Valentijn RM, Kaufmann RH, De La Rivière GB, Van Es LA. Presence of circulating macromolecular IgA in patients with hematuria due to primary IgA nephropathy. Am J Med 1983;74:375-80.
5. Valentijn RM, Radl J, Haaijman JJ, Vermeer BJ, Weening JJ, Kaufman RH, et al. Circulating and mesangial secretory component-binding IgA-1 in primary IgA nephropathy. Kidney Int 1984;26:760-6.
6. Kater L, Jobsis C, Beart De La Faille-Kuyper EH, Vogten AJM, Gigm R. Alcoholic hepatic disease: specificity of IgA deposits in liver. Am J Clin Pathol 1979;71:51-7.
7. Eknoyan G, Gyorkey F, Dichoso C, Martinez-Maldonado M, Suki W, Gyorkey P. Renal morphological and immunological changes associated with acute viral hepatitis. Kidney Int 1972;1:413-9.
8. Bailey RR, Burry AF, McGiven AR, Kirk JA, Laing JK, Moller P. A renal lesion in ankylosing spondylitis. Nephron 1980;26:171-3.
9. Rifai A, Small PA, Teague PO, Ayoub EM. Experimental IgA nephropathy. J Exp Med 1979;150:1161-73.
10. Hirokazu I, Yasushi N, Kenichi A, Kazunobu M, Tadashi Y, Akiba BM. Spontaneous glomerular IgA deposition in ddY mice: an animal model of IgA nephritis. Kidney Int 1987;27:756-61.
11. Rifai A. Experimental models for IgA-associated nephritis. Kidney Int 1987;31:1-7.
12. Coppo R, Basolo B, Mazzucco G, Bulzoni MR, Roccatello D, Messina M, et al. IgA1 and IgA2 in circulating immune complexes and renal deposits of Berger's and Schönlein-Henoch glomerulonephritis. Proc Eur Dial Transplant Assoc 1983;19:648-54.
13. Morel-Maroger L, Kram PR, Leroux-Robert C, Verger D, Richet G. Une nephropathie glomerulaire apparentment benigne: les depots fibrinoides inter-capillaires. Presse Med 1968;76:559-62.
14. Rodicio JL. Idiopathic IgA nephropathy. Kidney Int 1984;25:717-29.
15. D'Amico G, Imbasciati E, Barbiano di Belgioioso G, Bertoli S, Fogazzi G, Ferrario F, et al. Idiopathic IgA mesangial nephropathy: clinical and histological study of 374 patients. Medicine 1985;64:49-60.
16. Kinkaid-Smith P, Nicholis K. Mesangial IgA nephropathy. Am J Kidney Dis 1983;3:90-102.
17. Faedda R, Satta A, Bosincu L, Pirisi M, Bartoli E. Immune suppressive treatment of membranous glomerulonephritis. J Nephrol 1995;8:107-12.
18. Faedda R, Satta A, Tanda F, Pirisi M, Bartoli E. Immune suppressive treatment of membrano-proliferative glomerulonephritis. Nephron 1994;67: 59-65.
19. Julian BA, Waldo FB, Rifai A, Mestecky J. IgA nephropathy, the most common glomerulonephritis worldwide. Am J Med 1988;84:129-32.
20. Tu WH, Petitti DB, Biava CG, Tulunay O, Hopper J Jr. Membranous nephropathy: predictors of terminal renal failure. Nephron 1984;36:118-24.
21. Praga M, Gutierrez-Millet V, Navas JJ, Ruilope LM, Morales JM, Alcaz JM, et al. Acute worsening of renal function during episodes of macroscopic hematuria in IgA nephropathy. Kidney Int 1985;21:69-74.
22. Yoshikawa N, Iijima K, Maehara K, Yoshiara S, Yoshiya K, Matsuo T, et al. Mesangial changes in IgA nephropathy in children. Kidney Int 1987;32:585-9.
23. Emancipator SN. Immunoregulatory factors in the pathogenesis of IgA nephropathy. Kidney Int 1990; 38:1216-29.
24. D'Amico G, Minetti L, Ponticelli C, Fellin G, Ferrario F, Barbiano di Belgioioso G, et al. Prognostic indicators in idiopathic IgA mesangial nephropathy. Q J Med 1986;59:363-78.
25. Woo KT, Ghiang GSC, Lau YK, Lim CH. IgA nephritis in Singapore: clinical prognostic indices and treatment. Semin Nephrol 1987;7:379-81.
26. Clarkson AR, Seymour AE, Wooddroffe AJ, McKenjie PE, Chan L, Wootton AM. Controlled trial on phenytoin therapy in IgA nephropathy. Clin Nephrol 1980;13:215-8.
27. Egido J, Sanchez Crespo M, Sancho J, Hernando L. Phenytoin in the treatment of IgA mesangial glomerulonephritis (Berger's disease). Clin Nephrol 1981;16: 164-5.
28. Li HL, Hancock, Hooke DH, Dowling JP, Atkins RC. Mononuclear cell activation and decreased renal function in IgA nephropathy with crescents. Kidney Int 1990;37:1552-6.
29. Arima S, Nakayama M, Naito M, Sato T, Takahashi K. Significance of mononuclear phagocytes in IgA nephropathy. Kidney Int 1991;39:684-92.
30. Nakajima M, Hewitson TD, Mathews DC, Kincaid-Smith P. Platelet-derived growth factor mesangial deposits in mesangial IgA glomerulonephritis. Nephrol Dial Transplant 1991;6:11-6.
31. Bruns FJ, Adler S, Fraley DS, Segel DP. Sustained remission of membranous glomerulonephritis after cyclophosphamide and prednisone. Ann Intern Med 1991;114:725-30.
32. Brock N, Pohl J. Prevention of urotoxic side effects by regional detoxification with increased selectivity of oxazophosphorine cytostatics. IARC Sci Publ 1984; 78:269-79.
33. Thrasher JB, Miller GJ, Wettlaufer JN. Bladder leiomyosarcoma following cyclophosphamide therapy for lupus nephritis. J Urol 1990;143:119-21.
34. Levine EG, Bloomfield CD. Leukemias and myelodisplastic syndromes secondary to drug, radiation and environmental exposure. Semin Oncol 1992;19:47-84.
35. Zarrabi MH. Association of non-Hodgkin's lymphoma and second neoplasms. Semin Oncol 1990;17: 120-32.